Skip to main content
Aldo Conti

Dr Aldo Conti BSc (Hons), MSc, PhD, CPsychol

Postdoctoral Research Associate

Research interests

  • Neuroscience
  • Psychiatry
  • Child & Family

Contact details

Biography

Dr Aldo Conti is a Postdoctoral Research Associate at the Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care (FNMP), King’s College London, within the Division of Care in Long Term Conditions. His research examines the efficacy of brain stimulation, pharmacological, and behavioural interventions on clinical symptoms and neurocognitive functions in people with neurodevelopmental and psychiatric conditions. He also investigates the neurocognitive and cardiovascular effects of chronic psychoactive substance use. He has employed a broad range of research methods across his projects, including neuroimaging, neuropsychological assessments, clinical outcome data, and post-mortem analyses.

At FNMP, Dr Conti works on the FIRST PETT project, a parallel-group, single-masked (outcome assessor), 1:1 randomized controlled superiority trial evaluating the efficacy and mechanisms of the Fast Imagery Reversal Script for Trauma Release Protocol (FIRST Protocol) in reducing PTSD symptoms among UK military veterans. Previously, he worked on the ATTENS project at the Institute of Psychiatry, Psychology & Neuroscience, a multi-centre, double-blind, randomized, parallel-group, phase IIb trial investigating the efficacy of external Trigeminal Nerve Stimulation (TNS) on ADHD symptoms in youth.

Dr Conti earned his PhD in Addiction Medicine at the University of St Andrews and is a Chartered Psychologist with the British Psychological Society.

Research profile

    Research

    FP animation screenshot #4
    FIRST PETT

    FIRST PETT (Fast Image Reversal Script for Trauma-release PTSD Experimental Treatment Trial) assesses the efficacy of a novel treatment for PTSD in UK veterans

    Project status: Starting

    PONS Centre banner brain scan
    Developmental Neuroimaging

    Our research uses neuroimaging, neurocognitive, and psychopharmacological methods to better understand ADHD and related child psychiatric disorders as well as normal brain development from childhood to adulthood.

    News

    COMMENT: Brain device for ADHD shows no benefit in major UK trial

    Diagnoses of attention deficit hyperactivity disorder (ADHD) are rising rapidly in the UK. More children and teenagers than ever are being referred for...

    Sleeping child with trigeminal nerve stimulation (TNS) device_credit Astrid Perez (1)

    Brain stimulation device cleared for ADHD in the US is overall safe but ineffective

    A large multicentre clinical trial led by King’s College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD...

    Sleeping child with trigeminal nerve stimulation (TNS) device_credit Astrid Perez (1)

      Research

      FP animation screenshot #4
      FIRST PETT

      FIRST PETT (Fast Image Reversal Script for Trauma-release PTSD Experimental Treatment Trial) assesses the efficacy of a novel treatment for PTSD in UK veterans

      Project status: Starting

      PONS Centre banner brain scan
      Developmental Neuroimaging

      Our research uses neuroimaging, neurocognitive, and psychopharmacological methods to better understand ADHD and related child psychiatric disorders as well as normal brain development from childhood to adulthood.

      News

      COMMENT: Brain device for ADHD shows no benefit in major UK trial

      Diagnoses of attention deficit hyperactivity disorder (ADHD) are rising rapidly in the UK. More children and teenagers than ever are being referred for...

      Sleeping child with trigeminal nerve stimulation (TNS) device_credit Astrid Perez (1)

      Brain stimulation device cleared for ADHD in the US is overall safe but ineffective

      A large multicentre clinical trial led by King’s College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD...

      Sleeping child with trigeminal nerve stimulation (TNS) device_credit Astrid Perez (1)